| Literature DB >> 31888005 |
Paweł Kwiatkowski1, Łukasz Łopusiewicz2, Mateusz Kostek1, Emilia Drozłowska2, Agata Pruss3, Bartosz Wojciuk1, Monika Sienkiewicz4, Hanna Zielińska-Bliźniewska4, Barbara Dołęgowska3.
Abstract
In the post-antibiotic era the issue of bacterial resistance refers not only to antibiotics themselves but also to common antiseptics like octenidine dihydrochloride (OCT). This appears as an emerging challenge in terms of preventing staphylococcal infections, which are both potentially severe and easy to transfer horizontally. Essential oils have shown synergisms both with antibiotics and antiseptics. Therefore the aim of this study was to investigate the impact of lavender essential oil (LEO) on OCT efficiency towards methicillin-resistant S. aureus strains (MRSA). The LEO analyzed in this study increased the OCT's susceptibility against MRSA strains. Subsequent FTIR analysis revealed cellular wall modifications in MRSA strain cultured in media supplemented with OCT or LEO/OCT. In conclusion, LEO appears to be a promising candidate for an efficient enhancer of conventional antiseptics.Entities:
Keywords: FTIR; MRSA; lavender essential oil; octenidine dihydrochloride; synergistic activity
Mesh:
Substances:
Year: 2019 PMID: 31888005 PMCID: PMC6982929 DOI: 10.3390/molecules25010095
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Chemical composition of volatile constituents of commercial lavender essential oil from the flowering herb of Lavandula angustifolia Mill. (Lamiaceae).
| Compound | RI | Relative Concentration (%) |
|---|---|---|
|
| ||
| α-Pinene | 936 | 0.1 |
| Camphene | 950 | 0.1 |
| Myrcene | 987 | 2.4 |
| 1015 | 0.2 | |
| 1,8-Cineole | 1024 | 2.5 |
| Limonene | 1025 | 0.6 |
| ( | 1029 | 3.2 |
| ( | 1041 | 2.7 |
| γ-Terpinene | 1051 | 0.1 |
| Terpinolene | 1082 | 0.2 |
|
| ||
| Linalool | 1086 | 34.1 |
| Camphor | 1123 | 1.2 |
| Izoborneol | 1142 | 0.2 |
| Borneol | 1150 | 1.4 |
| Lavandulol | 1151 | 1.1 |
| Terpinene-4-ol | 1164 | 2.5 |
| 1172 | 0.2 | |
| α-Terpineol | 1176 | 1.8 |
| Linalyl acetate | 1239 | 33.3 |
| Lavandulyl acetate | 1275 | 3.2 |
| Neryl acetate | 1342 | 0.8 |
| Geranyl acetate | 1362 | 1.3 |
|
| ||
| β-Caryophyllene | 1421 | 2.7 |
| Aromadendrene | 1443 | 0.1 |
| ( | 1446 | 0.4 |
| Bicyclosesquiphellandrene | 1487 | 0.1 |
|
| ||
| Caryophyllene oxide | 1578 | 0.1 |
|
| ||
| Oct-1-en-3-yl acetate | 1093 | 0.6 |
|
| ||
| Octan-3-one | 969 | 1.3 |
| Total | 98.5 | |
RI: Retention index measured relative to n-alkanes (C-9 to C-26) on a non-polar Rtx-1 column.
Figure 1The chemical structures of the main compounds of lavender essential oil: linalool (a) and linalyl acetate (b).
Fractional inhibitory concentration (FIC) and FIC indices (FICI) of octenidine dihydrochloride (OCT)—lavender essential oil (LEO) pairs against methicillin-resistant Staphylococcus aureus (MRSA) strains.
| Bacteria | OCT-LEO | MICo | MBC | MICc | FIC | FICI | Type of Interaction | |
|---|---|---|---|---|---|---|---|---|
| reference strain | ATCC 43300 | OCT (µg/mL) | 1.95 ± 0.00 | 5.21 ± 2.26 | 0.12 ± 0.00 | 0.06 | 0.11 | synergy |
| LEO (mg/mL) | 18.29 ± 7.92 | 439.00 ± 0.00 | 0.86 ± 0.00 | 0.05 | ||||
| isolates | 1 | OCT (µg/mL) | 3.91 ± 0.00 | 11.72 ± 5.52 | 0.12 ± 0.00 | 0.03 | 0.16 | synergy |
| LEO (mg/mL) | 13.72 ± 0.00 | 27.44 ± 0.00 | 1.71 ± 0.00 | 0.13 | ||||
| 2 | OCT (µg/mL) | 3.52 ± 0.00 | 7.04 ± 0.00 | 0.24 ± 0.00 | 0.13 | 0.26 | synergy | |
| LEO (mg/mL) | 13.72 ± 0.00 | 27.44 ± 0.00 | 1.71 ± 0.00 | 0.13 | ||||
| 3 | OCT (µg/mL) | 3.52 ± 0.00 | 7.04 ± 0.00 | 0.12 ± 0.00 | 0.06 | 0.12 | synergy | |
| LEO (mg/mL) | 13.72 ± 0.00 | 27.44 ± 0.00 | 0.86 ± 0.00 | 0.06 |
Values are expressed as mean ± standard deviation. MICo, minimum inhibitory concentration of OCT or LEO; MBC, minimum bactericidal concentration; MICc, minimum inhibitory concentration of OCT/LEO combination. FIC index = FIC of OCT + FIC of LEO. FICI < 0.5, synergy; 0.5 ≤ FICI ≤ 1.0, addition; 1.1 < FICI ≤ 4.0, indifference; FICI > 4.0, antagonism. Using the known density of LEO, the final result was expressed in mg/mL.
Figure 2Time-kill kinetics of Staphylococcus aureus ATCC 43300 (MRSA) strain grown in Mueller-Hinton broth containing: no chemicals (control—medium A), Tween 80 (medium B), DMSO (medium C), Tween 80 and DMSO (medium D), lavender essential oil (LEO) at subinhibitory concentration (MIC50) (medium E), octenidine dihydrochloride (OCT) at subinhibitory concentration (MIC50) (medium F), LEO/OCT at subinhibitory concentrations (MICc50) (medium G). CFU—colony forming unit.
Figure 3FTIR spectra of Staphylococcus aureus ATCC 43300 (MRSA) strain grown in Mueller-Hinton broth containing: no chemicals (control—medium A), Tween 80 (medium B), DMSO (medium C), Tween 80 and DMSO (medium D), lavender essential oil (LEO) at subinhibitory concentration (MIC50) (medium E), octenidine dihydrochloride (OCT) at subinhibitory concentration (MIC50) (medium F), LEO/OCT at subinhibitory concentrations (MICc50) (medium G).
Figure 4FTIR spectra (in the range: 950–700 cm−1) of Staphylococcus aureus ATCC 43300 (MRSA) strain grown in Mueller-Hinton broth containing: no chemicals (control—medium A), lavender essential oil (LEO) at subinhibitory concentration (MIC50) (medium E), octenidine dihydrochloride (OCT) at subinhibitory concentration (MIC50) (medium F), LEO/OCT at subinhibitory concentrations (MICc50) (medium G).